References
- Mion G. History of anaesthesia: The ketamine story - past, present and future. Eur J Anaesthesiol. 2017; 34: 571–575.
- Ilkjaer S, Petersen KL, Brennum J, Wernberg M, Dahl JB. Effect of systemic N-methyl-D-aspartate receptor antagonist (ketamine) on primary and secondary hyperalgesia in humans. Br J Anaesth. 1996; 76: 829–834.
- Wachtel H, Turski L. Glutamate: A new target in schizophrenia? Trends Pharmacol Sci. 1990; 11: 219–220.
- Gosek P, Chojnacka M, Bieńkowski P, Świecicki Ł. Effectiveness of ketamine in depressed patients resistant to ECT or rTMS therapy. Psychiatr Pol. 2014; 48: 49–58.
- Schwartz J, Murrough JW, Iosifescu DV. Ketamine for treatment-resistant depression: Recent developments and clinical applications. Evid Based Ment Health. 2016; 19: 35–38.
- Serafini G, Howland R, Rovedi F, Girardi P, Amore M. The role of ketamine in treatment-resistant depression: A systematic review. Curr Neuropharmacol. 2014; 12: 444–461.
- Bobo WV, Voort JLV, Croarkin PE, Leung JG, Tye SJ, Frye MA. Ketamine for treatment-resistant unipolar and bipolar major depression: Critical review and implications for clinical practice. Depress Anxiety. 2016; 33: 698–710.
- Nowak W, Grendas LN, Sanmarco LM, Estecho IG, Arena ÁR, Eberhardt N, Rodante DE, Aoki MP, Daray FM, Carrera Silva EA, Errasti AE. Pro-inflammatory monocyte profile in patients with major depressive disorder and suicide behaviour and how ketamine induces anti-inflammatory M2 macrophages by NMDAR and mTOR. EBioMedicine. 2019; 50: 290–305.
- Szałach ŁP, Lisowska KA, Cubała WJ. The influence of antidepressants on the immune system. Arch Immunol Ther Exp. 2019; 67: 143–151.
- Begec Z, Yucel A, Yakupogullari Y, Erdogan MA, Duman Y, Durmus M, Ersoy MO. The antimicrobial effects of ketamine combined with propofol: An in vitro study. Braz J Anesthesiol. 2013; 63: 461–465.
- Gocmen S, Buyukkocak U, Caglayan O. In vitro investigation of the antibacterial effect of ketamine. Ups J Med Sci. 2008; 113: 39–46.
- Kruszewska H, Zareba T, Tyski S. Search of antimicrobial activity of selected non-antibiotic drugs. Acta Pol Pharm. 2002; 59: 436–439.
- Anders HJ, Lichtnekert J, Allam R. Interferon-α and -β in kidney inflammation. Kidney Int. 2010; 77: 848–854.
- Doss SA, Tillotson GS, Amyes SGB. Effect of sub-inhibitory concentrations of antibiotics on the virulence of Staphylococcus aureus. J Appl Bacteriol. 1993; 75: 123–128.
- Hacker J, Ott M, Hof H. Effects of low, subinhibitory concentrations of antibiotics on expression of a virulence gene cluster of pathogenic Escherichia coli by using a wild-type gene fusion. Int J Antimicrob Agents. 1993; 2: 263–270.
- Lück PC, Schmitt JW, Hengerer A, Helbig JH. Subinhibitory concentrations of antimicrobial agents reduce the uptake of Legionella pneumophila into Acanthamoeba castellanii and U937 cells by altering the expression of virulence-associated antigens. Antimicrob Agents and Chemother. 1998; 42: 2870–2876.
- Nichterlein T, Domann E, Kretschmar M, Bauer M, Hlawatsch A, Hof H, Chakraborty T. Subinhibitory concentrations of β-lactams and other cell-wall antibiotics inhibit listeriolysin production by Listeria monocytogenes. Int J of Antimicrob Agents. 1996; 7: 75–81.
- Zanos P, Moaddel R, Morris PJ, Riggs LM, Highland JN, Georgiou P, Pereira EFR, Albuquerque EX, Thomas CJ, Zarate Jr CA, et al. Ketamine and ketamine metabolite pharmacology: Insights into therapeutic mechanisms. Pharmacol Rev. 2018; 70: 621–660.
- Getachew B, Aubee JI, Schottenfeld RS, Csoka AB, Thompson KM, Tizabi Y. Ketamine interactions with gut-microbiota in rats: Relevance to its antidepressant and anti-inflammatory properties. BMC Microbiol. 2018; 18: 222.
- Berk M, Williams LJ, Jacka FN, O’Neil A, Pasco JA, Moylan S, Allen NB, Stuart AL, Hayley AC, Byrne ML, Maes M. So depression is an inflammatory disease, but where does the inflammation come from? BMC Med. 2013; 11: 200.
- Modabbernia A, Taslimi S, Brietzke E, Ashrafi M. Cytokine alterations in bipolar disorder: A meta-analysis of 30 studies. Biol Psychiatry. 2013; 74: 15–25.
- Zarate CA, Brutsche N, Laje G, Luckenbaugh DA, Venkata SLV, Ramamoorthy A, Moaddel R, Wainer IW. Relationship of ketamine's plasma metabolites with response, diagnosis, and side effects in major depression. Biol Psychiatry. 2012; 72: 331–338.
- Strohalm M, Hassman M, Košata B, Kodíček M. mMass data miner: An open source alternative for mass spectrometric data analysis. Rapid Commun Mass Spectrom. 2008; 22: 905–908.
- Stępień-Pyśniak D, Hauschild T, Różański P, Marek A. MALDI-TOF mass spectrometry as a useful tool for identification of Enterococcus spp. from wild birds and differentiation of closely related species. J Microbiol Biotechnol. 2017; 27: 1128–1137.
- Chan KL, Cathomas F, Russo SJ. Central and peripheral inflammation link metabolic syndrome and major depressive disorder. Physiology. 2019; 34: 123–133.
- Zanos P, Gould TD. Mechanisms of ketamine action as an antidepressant. Mol Psychiatry. 2018; 23: 801–811.
- Comerlato CB, Zhang X, Walker K, Brandelli A, Figeys D. Comparative proteomic analysis reveals metabolic variability of probiotic Enterococcus durans during aerobic and anaerobic cultivation. J Proteomics. 2020; 220: 103764.
- Toyota S, Moriyama M, Otake T, Kono J, Shudou Y, Satake T, Seki K, Masuda S, Amaki Y. Effect of anaesthetic agents on the phagocytic function of human polymorphonuclear leukocytes through analysis with a phagocytic plaque method. Inflamm Res. 1995; 44: 204–206.
- Krumholz W, Endrass J, Hempelmann G. Inhibition of phagocytosis and killing of bacteria by anaesthetic agents in vitro. Br J Anaesth. 1995; 75: 66–70.
- Son KA, Kang JH, Yang MP. Ketamine inhibits the phagocytic responses of canine peripheral blood polymorphonuclear cells through the upregulation of prostaglandin E2 in peripheral blood mononuclear cells in vitro. Res Vet Sci. 2009; 87: 41–46.